Tectonic Therapeutic | AVRO - Gross Profit On Sales


Tectonic Therapeutic reported $0 in Gross Profit on Sales for its fiscal quarter ending in March of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alnylam Pharmaceuticals USD 825M 4.3M Mar/2026
Celltrion KRW 46.98B 579.12B Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Gilead Sciences USD 5.52B 791M Mar/2026
Ionis Pharmaceuticals USD 243M 48M Mar/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Karyopharm Therapeutics USD 32.6M 63.38M Dec/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
MacroGenics USD 31.11M 30.14M Dec/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Organigram Holdings CAD 23.32M 8.52M Dec/2025
Pfizer USD 11.04B 1.24B Mar/2026
Pharma Mar EUR 39.24M 47.46M Mar/2026
Qiagen NV USD 325.27M 19.53M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sanofi EUR 8.45B 1.31B Dec/2025
Sarepta Therapeutics USD 621.34M 577.79M Mar/2026
Sartorius EUR 414.5M 18.3M Mar/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Takeda JPY 688.84B 101.71B Mar/2026
Tilray USD 57.47M 10.16M Jun/2025
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026